facebook pixel
chevron_right Business
transparent transparent
Fosun Pharma to buy smaller stake in Gland for $1.09 bn
Gland, founded in 1978, develops generic injectables primarily for the US market as well as for India and some semi-regulated markets. As part of the deal the Chinese drug maker would acquire shares held by Gland Pharma founders and KKR. Some of these synergies include the bio-similar programme developed at Fosun being made available for manufacturing by Gland and introducing them to the Indian market.
For the best experience use Awesummly app on your Android phone
Awesummly Chrome Extension Awesummly Android App